On November 27, 2023, the Board of Directors of HOOKIPA Pharma Inc. changed the title of the Company?s current Chief Development Officer, Dr. Roman Necina, to Chief Operations Officer, effective January 1, 2024. Roman Necina, Ph.D., has served as the Company?s Chief Development Officer since July 2022. Prior to that he was the company's Chief Technology Officer from November 2019 through June 2022.

Dr. Necina?s biographical information is incorporated herein by reference from the Company?s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 13, 2023. There are no arrangements or understandings pursuant to which Dr. Necina was selected for his position, other than his existing employment contract with the Company which remains unchanged.